Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
about
COPD and its comorbidities: Impact, measurement and mechanismsComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementExcess costs of comorbidities in chronic obstructive pulmonary disease: a systematic reviewNew clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analysesImpact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009Determinants of elevated healthcare utilization in patients with COPDSleep quality predicts quality of life in chronic obstructive pulmonary disease.Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.COPD Hospitalization Risk Increased with Distinct Patterns of Multiple Systems Comorbidities Unveiled by Network Modeling.Response to a mobile health decision-support system for screening and management of tobacco use.Economic Burden of COPD in the Presence of Comorbidities.Barriers to adherence to COPD guidelines among primary care providers.Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPDImpact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.Delivering cost-effective care for COPD in the USA: recent progress and current challenges.Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services.Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.Chronic Obstructive Pulmonary Disease and the Risk of Stroke.Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea.The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong.Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries.Economic burden of COPD in a Swedish cohort: the ARCTIC study.Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population.Lung, Fat and Bone: Increased Adiponectin Associates with the Combination of Smoking-Related Lung Disease and Osteoporosis
P2860
Q26786812-481D0072-D923-4F7F-B895-AD5F2BD42A02Q26799659-C339DCC4-5C0E-40B3-83A0-7BDB0E662C13Q26828976-C4928828-B30E-4720-90CA-BC4688DF3263Q30419928-93C5F3E9-41EC-4F95-BDBB-752C27B2D84DQ33567206-2824ED28-3DC5-4053-BFB3-E79E740D88DCQ34547146-315FEE34-34A7-4366-B1F0-DDDEF8919770Q34554803-AF4C0957-538D-4C35-9465-72B3C3512812Q35087187-3C4B05EF-9035-40AF-AEE8-F0F11F57E2B5Q35570302-427897BB-CBE2-4EFF-8702-872938FFBB50Q35586124-A599AE66-A35D-4C90-ADE1-408D485FD119Q35825585-5F7D540C-1B4E-411F-88C2-0E699BB4D414Q36040587-31B04DD1-7D52-451F-BDEC-AB05A360F244Q36694313-E7368EA2-F267-46D3-B12A-36D8C99A9A59Q37669183-D91C655A-2C09-42DE-B384-4D82DE5DDBA3Q38068458-A718EDAA-339A-44EA-9C4E-7E6EBAA63C73Q38119867-519CE8D5-EDC5-40DA-9D44-967518555C2EQ38944856-1A0414AB-43DB-4D83-9587-BCAC60EB9E0BQ39268464-C00FE72E-B63B-48D4-B767-825BE91F29D4Q39642057-50923A1A-6227-407F-95C7-DF20939919C6Q44210553-AE34AC19-7825-4511-BE70-1B368FCF27A9Q46019872-A596BB75-CCCF-4C16-8395-D3B4C1761801Q47447790-9EC10E99-9923-4F0E-90EE-DFA0DCC7A7C1Q47637962-6686F26C-E1B1-4DC7-8C8A-F0F89BC76A1CQ48809034-A3125ADD-9A5B-483C-898A-39437C4E86E8Q58131522-76273E80-3B97-4BA3-8C2E-8EB6A220C66D
P2860
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@en
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@nl
type
label
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@en
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@nl
prefLabel
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@en
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@nl
P2093
P1433
P1476
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
@en
P2093
Fadia T Shaya
Pei-Jung Lin
Steven M Scharf
P304
P356
10.1016/J.RMED.2009.11.009
P577
2009-12-02T00:00:00Z